Drug-Target Information | ||||||||
---|---|---|---|---|---|---|---|---|
Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
pseudoephedrine | alpha-1a adrenergic receptor | small molecule | NA | drugbank , DGIDB | Nose[MeSHID:D009666] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.21 | approved | agonist |
pseudoephedrine | alpha-2a adrenergic receptor | small molecule | NA | drugbank , DGIDB | Nose[MeSHID:D009666] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.22 | approved | agonist |
pseudoephedrine | beta-1 adrenergic receptor | small molecule | NA | drugbank | Nose[MeSHID:D009666] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | agonist,partial agonist |
pseudoephedrine | beta-2 adrenergic receptor | small molecule | NA | drugbank , DGIDB | Nose[MeSHID:D009666] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.11 | approved | partial agonist |
pseudoephedrine | activator protein 1 | small molecule | NA | drugbank | Nose[MeSHID:D009666] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | inhibitor |
pseudoephedrine | activator protein 1 | small molecule | NA | drugbank | Nose[MeSHID:D009666] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | inhibitor |
pseudoephedrine | activator protein 1 | small molecule | NA | drugbank | Nose[MeSHID:D009666] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | inhibitor |
pseudoephedrine | activator protein 1 | small molecule | NA | drugbank | Nose[MeSHID:D009666] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | inhibitor |
pseudoephedrine | activator protein 1 | small molecule | NA | drugbank | Nose[MeSHID:D009666] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | inhibitor |
pseudoephedrine | activator protein 1 | small molecule | NA | drugbank | Nose[MeSHID:D009666] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | inhibitor |
pseudoephedrine | activator protein 1 | small molecule | NA | drugbank | Nose[MeSHID:D009666] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | inhibitor |
pseudoephedrine | dopamine d2 receptor | NA | Successful target | TTD , DGIDB | Nose[MeSHID:D009666] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.02 | approved | unknown |
pseudoephedrine | activator protein 1 | small molecule | NA | drugbank | Nose[MeSHID:D009666] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | inhibitor |
pseudoephedrine | interleukin-2 | small molecule | NA | drugbank | Nose[MeSHID:D009666] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | inhibitor |
pseudoephedrine | activator protein 1 | small molecule | NA | drugbank | Nose[MeSHID:D009666] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | inhibitor |
pseudoephedrine | activator protein 1 | small molecule | NA | drugbank | Nose[MeSHID:D009666] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | inhibitor |
pseudoephedrine | nuclear factor of activated t-cells, cytoplasmic 1 | small molecule | NA | drugbank | Nose[MeSHID:D009666] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | inhibitor |
pseudoephedrine | nuclear factor nf-kappa-b p105 subunit | small molecule | NA | drugbank | Nose[MeSHID:D009666] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | inhibitor |
pseudoephedrine | sodium-dependent noradrenaline transporter | small molecule | NA | drugbank , DGIDB | Nose[MeSHID:D009666] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.23 | approved | inhibitor |
pseudoephedrine | sodium-dependent dopamine transporter | small molecule | NA | drugbank , DGIDB | Nose[MeSHID:D009666] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.19 | approved | inhibitor |
pseudoephedrine | sodium-dependent serotonin transporter | small molecule | NA | drugbank , DGIDB | Nose[MeSHID:D009666] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.13 | approved | inhibitor |
pseudoephedrine | tumor necrosis factor | small molecule | NA | drugbank | Nose[MeSHID:D009666] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved | inhibitor |
click here to return to the previous page |